Key facts
- It has raised $1.2M; the latest was Angel (individual) ($1.2M) in Nov 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Aphasix
- ·The full record, as it builds
Funding rounds
No funding rounds for Aphasix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aphasix
Developer of a healthcare platform designed to assist individuals affected by aphasia, a language disorder commonly resulting from stroke or other brain injuries. The company's platform offers exercises designed to enhance speaking, reading, and comprehension abilities, using artificial intelligence to frame the exercises to each patient's specific needs, and facilitates involvement of caregivers and family members by allowing them to monitor patient progress, providing users with additional opportunities to train at home.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2024
- Website
- aphasix.com/
- Ownership
- Privately Held (backing)
Aphasix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aphasix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aphasix in its N-PORT filings yet. We sweep new filings monthly.